Blueprint Medicines Corp (BPMC)

02:21 AM

Blueprint Medicines stock hits 52-week low at $80.64 - Investing.com

02:21 AM

Apr 02, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Bought by Vanguard Group Inc. - MarketBeat

Apr 02, 2025

Apr 01, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Corebridge Financial Inc. - The AM Reporter

Apr 01, 2025

Mar 31, 2025

Exclusive: Blueprint Medicines Leadership Takes Center Stage at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 30, 2025

Is Blueprint Medicines (BPMC) One of the Best Mid Cap Biotech Stocks to Buy? - Insider Monkey

Mar 30, 2025

Mar 27, 2025

Blueprint Medicines at H.C. Wainwright Conference: Strategic Pipeline Expansion - Investing.com

Mar 27, 2025

Mar 27, 2025

Blueprint Medicines at H.C. Wainwright Conference: Strategic Pipeline Expansion By Investing.com - Investing.com UK

Mar 27, 2025

Mar 26, 2025

Blueprint Medicines COO Christina Rossi sells shares worth $216,075 By Investing.com - Investing.com Canada

Mar 26, 2025

Mar 26, 2025

Blueprint Medicines COO Christina Rossi sells shares worth $216,075 - Investing.com India

Mar 26, 2025

Mar 25, 2025

Is Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance

Mar 25, 2025

Mar 25, 2025

PNC Financial Services Group Inc. Boosts Stake in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Mar 25, 2025

Mar 22, 2025

Proficio Capital Partners LLC Makes New $1.01 Million Investment in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Mar 22, 2025

Mar 21, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Mar 21, 2025

Mar 20, 2025

The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts - Benzinga

Mar 20, 2025

Mar 20, 2025

Blueprint Medicines (BPMC): Among Stocks Insiders Are Selling In March - Insider Monkey

Mar 20, 2025

Mar 20, 2025

Morgan Stanley sets Blueprint Medicines stock at Equalweight, $100 target - Investing.com

Mar 20, 2025

Mar 20, 2025

Morgan Stanley sets Blueprint Medicines stock at Equalweight, $100 target By Investing.com - Investing.com UK

Mar 20, 2025

Mar 19, 2025

Blueprint Medicines’ SWOT analysis: stock poised for growth amid challenges - Investing.com

Mar 19, 2025

Mar 19, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Victory Capital Management Inc. - Defense World

Mar 19, 2025

Mar 18, 2025

Wolfe Research initiates Blueprint Medicines with Outperform rating - Investing.com

Mar 18, 2025

Mar 18, 2025

Blueprint Medicines (NASDAQ:BPMC) Now Covered by Jefferies Financial Group - Defense World

Mar 18, 2025

Mar 17, 2025

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 17, 2025

Mar 17, 2025

241,966 Shares in Blueprint Medicines Co. (NASDAQ:BPMC) Purchased by Raymond James Financial Inc. - Defense World

Mar 17, 2025

Mar 17, 2025

Blueprint Medicines initiated with a Buy at Jefferies - TipRanks

Mar 17, 2025

Mar 17, 2025

Jefferies sets Blueprint Medicines stock Buy rating, $135 target - Investing.com

Mar 17, 2025

Mar 17, 2025

Jefferies sets Blueprint Medicines stock Buy rating, $135 target By Investing.com - Investing.com Philippines

Mar 17, 2025

Mar 16, 2025

Blueprint Medicines (NASDAQ:BPMC) Shares Down 1.6% – Here’s Why - Defense World

Mar 16, 2025

Mar 15, 2025

Blueprint Medicines director Jeffrey Albers sells $658,500 in stock By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 15, 2025

Steward Partners Investment Advisory LLC Lowers Position in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Mar 15, 2025

Mar 15, 2025

Blueprint Medicines director Jeffrey Albers sells $658,500 in stock - Investing.com India

Mar 15, 2025

Mar 14, 2025

Charles Schwab Investment Management Inc. Purchases 7,165 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Mar 14, 2025

Mar 13, 2025

Blueprint Medicines’ SWOT analysis: strong Ayvakit sales drive stock outlook By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 13, 2025

Blueprint Medicines’ SWOT analysis: strong Ayvakit sales drive stock outlook - Investing.com

Mar 13, 2025

Mar 10, 2025

US Bancorp DE Sells 1,988 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Mar 10, 2025

Mar 10, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Stock Holdings Lifted by Bank of New York Mellon Corp - Defense World

Mar 10, 2025

Mar 09, 2025

Blueprint Medicines (NASDAQ:BPMC) Coverage Initiated at Scotiabank - Defense World

Mar 09, 2025

Mar 08, 2025

Blueprint Medicines CFO sells shares worth $469,219 By Investing.com - Investing.com South Africa

Mar 08, 2025

Mar 08, 2025

Proficio Capital Partners LLC Purchases Shares of 11,600 Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Mar 08, 2025

Mar 08, 2025

Zacks Research Has Positive Outlook for BPMC Q1 Earnings - Defense World

Mar 08, 2025

Mar 07, 2025

Blueprint Medicines Stock: Executives Sell Shares Amid Growth - sharewise

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines CMO Hewes L. Becker sells $890k in stock - Investing.com Canada

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines CEO sells $1.43 million in stock By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines EVP sells shares worth $467,265 By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines CEO sells $1.43 million in stock - Investing.com

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines EVP sells shares worth $467,265 - Investing.com India

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines chief commercial officer Lee Philina sells $331,490 in stock - Investing.com

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines CFO sells shares worth $469,219 - Investing.com

Mar 07, 2025

Mar 07, 2025

Blueprint Medicines Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 07, 2025